918²©ÌìÌÃ

±»ºöÊÓµÄÒÖÓôÖ¢Ö¢×´£¬£¬£¬£¬£¬ £¬£¬£¬ÕâЩÈÏÖªÖ¢×´Ð辯Ì裡


ʱ¼ä£º

2024-10-11

±»ºöÊÓµÄÒÖÓôÖ¢Ö¢×´£¬£¬£¬£¬£¬£¬£¬£¬ÕâЩÈÏÖªÖ¢×´Ð辯Ì裡

 

ÒÖÓôÖ¢(major depressive disorder£¬£¬£¬£¬£¬ £¬£¬£¬MDD)ÊǾ«ÉñÕϰ­µÄ³£¼ûÀàÐÍ£¬£¬£¬£¬£¬ £¬£¬£¬ÆäÁÙ´²±íÏÖ°üÀ¨Çé¸ÐÖ¢×´¡¢ÇûÌåÖ¢×´ºÍÈÏÖªÖ¢×´3¸öά¶È£¬£¬£¬£¬£¬ £¬£¬£¬³£»£»£»£»£»£»£»áÔì³É²»Í¬³Ì¶ÈµÄ¹¦ÄÜË𺦣¬£¬£¬£¬£¬ £¬£¬£¬Ó°Ï컼ÕߵŤ×÷¡¢Ñ§Ï°ºÍÉç»áÉú»î¡£¡£¡£¡£¡£Öйú¾«ÉñÎÀÉúµ÷²éÏÔʾÎÒ¹úÒÖÓôÕϰ­ÖÕÉú»¼²¡ÂÊΪ6.8%[1] £¬£¬£¬£¬£¬ £¬£¬£¬×Ü»¼²¡ÈËÊý³¬¹ý9000Íò¡£¡£¡£¡£¡£

        ÆäÖУ¬£¬£¬£¬£¬ £¬£¬£¬ÈÏÖªÖ¢×´Ö÷Òª±íÏÖΪִÐй¦ÄÜ¡¢×¢ÒâÁ¦¡¢¼ÇÒäÁ¦¡¢ÐÅÏ¢¼Ó¹¤Ëٶȵȷ½ÃæµÄ¹¦ÄÜÊÜË𡣡£¡£¡£¡£Ïà±ÈÓÚ¶ÔÇé¸ÐÖ¢×´£¨ÈçÇéÐ÷µÍÂ䣩¡¢ÇûÌåÖ¢×´£¨ÈçʧÃß¡¢ÌåÖØ¼õÇᡢʳÓû¼õÍË£©µÄÁ˽⣬£¬£¬£¬£¬ £¬£¬£¬ÒÖÓôÖ¢ÈÏÖªÖ¢×´ÍùÍùÊDZ»ºöÊӵĴæÔÚ£¬£¬£¬£¬£¬ £¬£¬£¬ÀýÈç˼¿¼¼°¼¯ÖÐ×¢ÒâµÄÄÜÁ¦Ï½µ¡¢ÄÑÒÔ×ö³ö¾ö¶¨µÈ£¬£¬£¬£¬£¬ £¬£¬£¬¶¼ÊÇÒÖÓôÖ¢µÄÁÙ´²±íÏÖÖ®Ò»[2] ¡£¡£¡£¡£¡£

ÒÖÓôÖ¢µÄ

ÈÏÖªÖ¢×´

ÈÏÖªÖ¢×´¹ã·º´æÔÚÓÚÒÖÓôÖ¢»¼ÕßÖУ¬£¬£¬£¬£¬ £¬£¬£¬¹á´©ÓÚÒÖÓô֢ȫ²¡³Ì£¬£¬£¬£¬£¬ £¬£¬£¬¿É³öÏÖÓÚÒÖÓôÖ¢ÒÖÓô·¢×÷ǰÇýÆÚ¡¢¼±ÐÔ·¢×÷ÆÚ£¨·¢ÉúÂÊ76.9%~94.0%£©¼°»º½âÆÚ£¨·¢ÉúÂÊ32.4%~44.0%£©[3] ¡£¡£¡£¡£¡£

 

À´×ÔºÉÀ¼µÄÒ»ÏîΪÆÚ3ÄêµÄǰհÐÔÑо¿£¬£¬£¬£¬£¬ £¬£¬£¬¹²ÄÉÈë267ÀýÒÖÓôÖ¢»¼Õߣ¬£¬£¬£¬£¬ £¬£¬£¬¹Û²ìÒÖÓôÖ¢²ÐÁôÖ¢×´ÔÚÒÖÓôÖ¢·¢×÷ÆÚºÍ»º½âÆÚµÄ´æÔÚÇé¿ö¡£¡£¡£¡£¡£½á¹ûÏÔʾ£¬£¬£¬£¬£¬ £¬£¬£¬ÔÚÒÖÓôÖ¢·¢×÷ÆÚ£¬£¬£¬£¬£¬ £¬£¬£¬ÈÏÖªÖ¢×´·Ç³£³£¼û£¬£¬£¬£¬£¬ £¬£¬£¬½ö´ÎÓÚÇéÐ÷µÍÂä/ÐËȤ¼õÍË£»£»£»£»£»£»£»ÔÚÒÖÓôÖ¢»º½âÆÚ£¬£¬£¬£¬£¬ £¬£¬£¬ÈÏÖªÖ¢×´ÊÇÒÖÓôÖ¢×î³£¼ûµÄ²ÐÁôÖ¢×´£¬£¬£¬£¬£¬ £¬£¬£¬ÊÇÇéÐ÷µÍÂä/ÐËȤ¼õÍ˵Ä2±¶[4] ¡£¡£¡£¡£¡£

Ñо¿·¢ÏÖ£¬£¬£¬£¬£¬ £¬£¬£¬¼´Ê¹Çé¸ÐÖ¢×´ÒÑÍêÈ«»ò²¿·Ö»º½âµÄÒÖÓôÖ¢»¼Õߣ¬£¬£¬£¬£¬ £¬£¬£¬ÈÏÖª¹¦ÄÜÕϰ­ÈÔ´æÔÚ£¬£¬£¬£¬£¬ £¬£¬£¬»¼Õ߻ᷢÏÖ×Ô¼º×¢ÒâÁ¦²»¼¯ÖС¢¼ÇÒäÁ¦²»¼Ñ¡¢Ö´ÐÐÁ¦²»Ç¿£¬£¬£¬£¬£¬ £¬£¬£¬ÈÏÖª¹¦ÄÜûÓеõ½»Ö¸´£¬£¬£¬£¬£¬ £¬£¬£¬Ó°Ï칤×÷ЧÂʼ°ÈÕ³£Éú»î£¬£¬£¬£¬£¬ £¬£¬£¬µ¼Ö²¿·ÖÒÖÓôÖ¢»¼ÕßÄÑÒÔ»Ö¸´Õý³£Éç»á¹¦ÄÜ¡¢ÍêÈ«¿µ¸´£¬£¬£¬£¬£¬ £¬£¬£¬»¹¿ÉÄÜ»áÔö¼ÓÒÖÓôÖ¢µÄ¸´È¼¼°¸´·¢µÄ·çÏÕ¡£¡£¡£¡£¡£

 

2019ÄêÁøÒ¶µ¶ÔÓÖ¾·¢±íµÄһƪÜöÝÍ·ÖÎöÖÐÌáµ½£¬£¬£¬£¬£¬ £¬£¬£¬×¢ÒâÁ¦¡¢¹¤×÷¼ÇÒäºÍ³¤ÆÚ¼ÇÒäµÄȱÏÝÔÚÖØÐÔÒÖÓô·¢×÷»º½âºó³ÖÐø´æÔÚ£¬£¬£¬£¬£¬ £¬£¬£¬²¢ÇÒÕâЩÈÏÖªÖ¢×´»áËæ×ÅÒÖÓôÖ¢·´¸´·¢×÷¶ø¶ñ»¯[5]¡£¡£¡£¡£¡£1Ïî¹ØÓÚÒÖÓôÖ¢»º½âÆÚÈÏÖª¹¦ÄܵÄÑо¿ÏÔʾ£¬£¬£¬£¬£¬ £¬£¬£¬30£¥µÄ»¼ÕßÔÚÒÖÓôÖ¢×´´ïµ½ÁÙ´²»º½âºóÈÔÈ»ÓÐ×¢ÒâÁ¦²»¼¯ÖС¢¼ÇÒäÁ¦²îµÈÍ»³öÎÊÌâ[6]¡£¡£¡£¡£¡£

 

¡¶ÖйúÒÖÓôÕϰ­·ÀÖÎÖ¸ÄÏ¡·(µÚ¶þ°æ) Ã÷È·Ö¸³ö£¬£¬£¬£¬£¬ £¬£¬£¬ÒÖÓôÖ¢³É¹¦ÖÎÁƵĹؼüÔÚÓÚ³¹µ×Ïû³ýÁÙ´²Ö¢×´£¬£¬£¬£¬£¬ £¬£¬£¬¼õÉÙ¸´·¢·çÏÕ£»£»£»£»£»£»£»Ìá¸ßÉú´æÖÊÁ¿£¬£¬£¬£¬£¬ £¬£¬£¬»Ö¸´Éç»á¹¦ÄÜ£¬£¬£¬£¬£¬ £¬£¬£¬´ïµ½ÕæÕýµÄÁÙ´²ÖÎÓú[7]¡£¡£¡£¡£¡£Õâ¾ÍÒªÇóÒÖÓôÖ¢·ÀÖÎÐèÖØÊÓÈÏÖªÖ¢×´µÄ¸ÉÔ¤¡£¡£¡£¡£¡£

 

ÁøÒ¶µ¶ÔÓÖ¾·¢±íµÄ1ÏîÄÉÈë1008ÀýÒÖÓôÖ¢»¼ÕߵĹú¼Ê´ó¹æÄ£Ëæ»ú¶ÔÕÕÑо¿ÏÔʾ£¬£¬£¬£¬£¬ £¬£¬£¬¾­¹ýΪÆÚ8ÖܵÄÖÎÁÆ£¬£¬£¬£¬£¬ £¬£¬£¬°¬Ë¾Î÷̪ÆÕÀ¼¡¢ÉáÇúÁÖ¼°ÎÄÀ­·¨ÐÁ¾ùÎÞ·¨ÓÐЧ¸ÄÉÆÒÖÓôÖ¢»¼ÕßµÄÈÏÖªÖ¢×´[8]¡£¡£¡£¡£¡£

 

Ò»ÏîÍøÂçÜöÝÍ·ÖÎö£¬£¬£¬£¬£¬ £¬£¬£¬Í¨¹ýÊý¾Ý¿â¡¢ÁÙ´²ÊÔÑé×¢²áÖÐÐĺÍÏà¹Ø»áÒéÕªÒªÒÔÆÀ¹À¸÷À࿹ÒÖÓôÒ©¶ÔÈÏÖªÖ¢×´µÄ¸ÄÉÆÇé¿ö£¬£¬£¬£¬£¬ £¬£¬£¬½á¹ûÏÔʾ£¬£¬£¬£¬£¬ £¬£¬£¬·üÁòÎ÷Í¡¶ÔÒÖÓôÖ¢»¼ÕßÈÏÖªÖ¢×´µÄ¸ÄÉÆÏÔÖøÓÅÓÚ°²Î¿¼Á[9]¡£¡£¡£¡£¡£

·üÁòÎ÷Í¡¶ÔÒÖÓôÖ¢ÈÏÖªÖ¢×´

µÄ»ý¼«×÷ÓÃ

·üÁòÎ÷Í¡ÊÇÒ»ÖÖ¶à°Ðµã¡¢¶àģʽµÄÐÂÐÍ¿¹ÒÖÓôÒ©£¬£¬£¬£¬£¬ £¬£¬£¬Ëüͨ¹ýÁ½ÖÖ²»Í¬µÄ×÷ÓÃģʽ£¬£¬£¬£¬£¬ £¬£¬£¬ÒÖÖÆSERTµÄÔÙÉãÈ¡ºÍ²ÎÓëµ÷½Ú5-HTÊÜÌ壬£¬£¬£¬£¬ £¬£¬£¬×÷ÓÃÓÚÁù¸öÒ©Àíѧ°Ðµã£¨Þ׿¹5-HT3R¡¢Þ׿¹5-HT7R¡¢Þ׿¹5-HT1DR¡¢²¿·Ö¼¤¶¯5-HT1BR¡¢¼¤¶¯5-HT1AR¡¢ÒÖÖÆSERT£©·¢»Ó¿¹ÒÖÓôÁÆÐ§¡£¡£¡£¡£¡£ÁÙ´²Ç°Ñо¿±íÃ÷£¬£¬£¬£¬£¬ £¬£¬£¬5-HT3¡¢5-HT7ÊÜÌåÞ׿¹×÷ÓÃÒÔ¼°5-HT1AÊÜÌ弤¶¯×÷ÓÿÉÄܶ԰üÀ¨¼ÇÒäÔÚÄÚµÄÈÏÖª¹¦ÄܲúÉú»ý¼«Ó°Ï죬£¬£¬£¬£¬ £¬£¬£¬Ìáʾ·üÁòÎ÷Í¡¶ÔÈÏÖªÖ¢×´µÄ»ý¼«×÷Óᣡ£¡£¡£¡£

 

2018Äê5ÔÂ2ÈÕ£¬£¬£¬£¬£¬ £¬£¬£¬ÃÀ¹úʳƷҩƷ¼à¶½¹ÜÀí¾Ö£¨FDA£©Í¨¹ýÁË·üÁòÎ÷Í¡µÄÒ»Ïî²¹³äÁÙ´²Ó¦Ó㬣¬£¬£¬£¬ £¬£¬£¬¼´¸ÄÉÆÒÖÓôÖ¢£¨MDD£©¼±ÐÔÆÚ»¼ÕßÈÏÖª¹¦ÄܵÄÒ»¸öÖØÒªÎ¬¶È¡ª¡ªÐÅÏ¢¼Ó¹¤ËÙ¶È£¬£¬£¬£¬£¬ £¬£¬£¬Õë¶ÔÒÖÓôÖ¢°éÈÏÖª¹¦ÄÜÕϰ­µÄ»¼Õߣ¬£¬£¬£¬£¬ £¬£¬£¬·üÁòÎ÷Í¡ÊÇÓµÓÐI¼¶Ö¤¾ÝµÄ¿¹ÒÖÓôÒ©¡£¡£¡£¡£¡£

 

Ò»ÏîËæ»ú¡¢Ë«Ã¤¡¢°²Î¿¼Á¶ÔÕÕÑо¿£¬£¬£¬£¬£¬ £¬£¬£¬ÄÉÈëÀ´×Ô12¸ö¹ú¼ÒµÄ602ÃûÒÖÓôÖ¢»¼Õߣ¬£¬£¬£¬£¬ £¬£¬£¬·Ö±ð¸øÓè·üÁòÎ÷Í¡10mg/Ìì¡¢·üÁòÎ÷Í¡20mg/Ìì¡¢°²Î¿¼ÁÖÎÁÆ8ÖÜ£¬£¬£¬£¬£¬ £¬£¬£¬Ê¹ÓÃPDQÆÀ¹À»¼ÕßµÄÈÏÖªÖ¢×´¡£¡£¡£¡£¡£½á¹ûÏÔʾ£¬£¬£¬£¬£¬ £¬£¬£¬·üÁòÎ÷Í¡ÏÔÖø¸ÄÉÆÒÖÓô»¼Õߵĸ÷ÏîÈÏÖªÖ¢×´[10]¡£¡£¡£¡£¡£

ÈÏÖªÖ¢×´ÊÇÒÖÓôÖ¢µÄºËÐÄÖ¢×´Ö®Ò»£¬£¬£¬£¬£¬ £¬£¬£¬¿É³öÏÖÓÚÒÖÓôÖ¢ÒÖÓô·¢×÷ǰÇýÆÚ¡¢¼±ÐÔ·¢×÷ÆÚ¼°»º½âÆÚ£¬£¬£¬£¬£¬ £¬£¬£¬±»ºöÊÓµÄÈÏÖªÖ¢×´»á³ÉΪ»º½âÆÚºóµÄÖ÷Òª²ÐÁôÖ¢×´£¬£¬£¬£¬£¬ £¬£¬£¬Ó°ÏìÒÖÓôÖ¢»¼ÕߵĻָ´£¬£¬£¬£¬£¬ £¬£¬£¬²¢Ôö¼ÓÒÖÓôÖ¢¸´È¼¡¢¸´·¢µÄ·çÏÕ¡£¡£¡£¡£¡£Ïà±ÈÓÚÇé¸ÐÖ¢×´£¬£¬£¬£¬£¬ £¬£¬£¬¶ÔÒÖÓôÖ¢»¼ÕßÈÏÖªÖ¢×´µÄÖØÊӳ̶Ȼ¹´æÔÚÃ÷ÏÔ²»×㣬£¬£¬£¬£¬ £¬£¬£¬ÁÙ´²ÉÏÓ¦ÖØÊÓ¶ÔÒÖÓôÖ¢»¼ÕßÈÏÖªÖ¢×´µÄʶ±ðºÍ¸ÉÔ¤¡£¡£¡£¡£¡£·üÁòÎ÷Í¡ÊÇÒ»ÖÖ¶à°Ðµã¡¢¶àģʽµÄÐÂÐÍ¿¹ÒÖÓôÒ©£¬£¬£¬£¬£¬ £¬£¬£¬ÔÚ¸ÄÉÆÒÖÓôÇéÐ÷µÄͬʱ¿ÉÒÔÏÔÖø¸ÄÉÆÈÏÖªÖ¢×´£¬£¬£¬£¬£¬ £¬£¬£¬Ïà½ÏÓÚSSRI¡¢SNRIµÈ£¬£¬£¬£¬£¬ £¬£¬£¬·üÁòÎ÷Í¡ÔÚ¸ÄÉÆÈÏÖªÖ¢×´µÄÁÙ´²Ñо¿½á¹û¸üºÃ£¬£¬£¬£¬£¬ £¬£¬£¬ÇÒÆäÈÏÖªÖ¢×´¸ÄÉÆµÄЧӦÊÇÖ±½ÓµÄ¡¢¶ÀÁ¢ÓÚÒÖÓôÖ¢×´¸ÄÉÆ¡£¡£¡£¡£¡£

 

²Î¿¼ÎÄÏ×

[1]Huang Y , Wang Y , Wang H ,et al. Prevalence of mental disorders in China: a cross-sectional epidemiological study[J]. Lancet Psychiatry, 2019,6(3):211-224. 

[2]ÑÖµ¤·å,ÀîÁè½­. ÒÖÓôÖ¢»¼ÕßµÄÈÏÖª¹¦ÄÜÕϰ­¼°ÆäÁÙ´²Æôʾ£ÛJ£Ý. Öлª¾«Éñ¿ÆÔÓÖ¾, 2018,51(5):343-346. 

[3] ÖлªÒ½Ñ§»á¾«Éñҽѧ·Ö»áÒÖÓôÕϰ­Ñо¿Ð­×÷×é. ÒÖÓôÖ¢ÈÏÖªÖ¢×´ÆÀ¹ÀÓë¸ÉԤר¼Ò¹²Ê¶[J]. Öлª¾«Éñ¿ÆÔÓÖ¾,2020,53(05)£º369-376.

[4] Conradi HJ, Ormel J, de Jonge P. Presence of individual (residual) symptoms during depressive episodes and periods of remission: a 3-year prospective study. Psychol Med. 2011 Jun;41(6):1165-74. 

[5]Semkovska M, Quinlivan L, O'Grady T, Johnson R, Collins A, O'Connor J, Knittle H, Ahern E, Gload T. Cognitive function following a major depressive episode: a systematic review and meta-analysis. Lancet Psychiatry. 2019 Oct;6(10):851-861.

[6]Hasselbalch BJ, Knorr U, Hasselbalch SG, Gade A, Kessing LV. The cumulative load of depressive illness is associated with cognitive function in the remitted state of unipolar depressive disorder. Eur Psychiatry. 2013 Aug;28(6):349-55.

[7]ÀîÁè½­,ÂíÐÁ. ÖйúÒÖÓôÕϰ­·ÀÖÎÖ¸ÄÏ£ÛM£Ý. 2°æ. ±±¾©:ÖлªÒ½Ñ§µç×ÓÒôÏñ³ö°æÉç, 2015.

[8]Shilyansky C, Williams LM, Gyurak A, Harris A, Usherwood T, Etkin A. Effect of antidepressant treatment on cognitive impairments associated with depression: a randomised longitudinal study. Lancet Psychiatry. 2016 May;3(5):425-35. 

[9]Baune BT, Brignone M, Larsen KG. A Network Meta-Analysis Comparing Effects of Various Antidepressant Classes on the Digit Symbol Substitution Test (DSST) as a Measure of Cognitive Dysfunction in Patients with Major Depressive Disorder. Int J Neuropsychopharmacol. 2018 Feb 1;21(2):97-107. 

[10]McIntyre RS, Lophaven S, Olsen CK. A randomized, double-blind, placebo-controlled study of vortioxetine on cognitive function in depressed adults. Int J Neuropsychopharmacol. 2014 Oct;17(10):1557-67.

 

ÌØ±ð˵Ã÷£º±¾ÎÄÄÚÈݲ¿·ÖÀ´Ô´ÒÔÉϲο¼ÎÄÏ×£¬£¬£¬£¬£¬ £¬£¬£¬½ö×öÐÅÏ¢ÕûºÏ·ÖÏí£¬£¬£¬£¬£¬ £¬£¬£¬²»´ú±íÈκÎÓÃÒ©½¨Ò飬£¬£¬£¬£¬ £¬£¬£¬ÈçÓÐÇÖȨ¡¢ÐÅÏ¢ÓÐÎó»òÆäËûÒìÒ飬£¬£¬£¬£¬ £¬£¬£¬ÇëÁªÏµ918²©ÌìÌýøÐÐɾ³ý£¡

 

¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿